MiMedx Sets September 30 Vote on $350M Sanara Acquisition
MDXG sits 50% above its 52-week low of $3.025.
Summary
MiMedx's proxy statement sets a September 30 shareholder vote on its $350M Sanara MedTech acquisition, with 39% of Sanara shares already committed to approve and $300M in debt financing secured.
Key Events · M&A and Partnerships · MDXG
-
Special Meeting Set for September 30
Sanara shareholders will vote on the merger at a virtual special meeting on September 30, 2026, with a record date of September 1, 2026. 9,188,035 Sanara shares are outstanding and entitled to vote.
-
39% of Shares Already Committed
A Voting Agreement with Chairman Ronald T. Nixon's affiliates covers 39.0% of Sanara's outstanding shares, requiring them to vote in favor of the merger and against any alternative acquisition proposal.
-
$300M Debt Financing Secured
MiMedx has a debt commitment letter from Hayfin Capital Management for a $300 million first lien senior secured term loan, with proceeds funding the cash portion of the merger consideration.
-
HSR Waiting Period Expires September 11
The Hart-Scott-Rodino antitrust waiting period is set to expire at 11:59 p.m. Eastern Time on September 11, 2026, unless extended or terminated earlier.
Analysis · MDXG · Industrial Applications And Services
This proxy statement/prospectus finalizes the shareholder approval process for MiMedx's $350 million acquisition of Sanara MedTech. The special meeting is set for September 30, 2026, with a record date of September 1, 2026. The filing reveals that 39.0% of Sanara shares are already committed to vote in favor via a Voting Agreement with Chairman Ronald T. Nixon's affiliates, significantly de-risking the approval. The deal is financed with a $300 million first lien term loan from Hayfin Capital Management, and the HSR waiting period expires September 11, 2026. Sanara shareholders will receive $33.00 cash plus 0.4735 MiMedx shares per Sanara share, implying $35.14 per share based on MiMedx's September 1 closing price of $4.52.
How filings like this one have moved
In the 30 days to Sep 9, 2026, 30% of the 1972 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.02%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MDXG was trading at $4.55 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $666.1M. The 52-week trading range was $3.03 to $7.97. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.